Bedel Financial Consulting’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,275
| Closed | -$83K | – | 503 |
|
|
2022
Q1 | $83K | Hold |
1,275
| – | – | 0.03% | 304 |
|
|
2021
Q4 | $85K | Hold |
1,275
| – | – | 0.03% | 307 |
|
|
2021
Q3 | $78K | Hold |
1,275
| – | – | 0.03% | 314 |
|
|
2021
Q2 | $79K | Hold |
1,275
| – | – | 0.03% | 312 |
|
|
2021
Q1 | $76K | Hold |
1,275
| – | – | 0.03% | 304 |
|
|
2020
Q4 | $76K | Hold |
1,275
| – | – | 0.03% | 263 |
|
|
2020
Q3 | $70K | Hold |
1,275
| – | – | 0.04% | 258 |
|
|
2020
Q2 | $65K | Hold |
1,275
| – | – | 0.04% | 252 |
|
|
2020
Q1 | $57K | Hold |
1,275
| – | – | 0.04% | 249 |
|
|
2019
Q4 | $68K | Hold |
1,275
| – | – | 0.04% | 253 |
|
|
2019
Q3 | $59K | Hold |
1,275
| – | – | 0.04% | 263 |
|
|
2019
Q2 | $64K | Hold |
1,275
| – | – | 0.04% | 251 |
|
|
2019
Q1 | $65K | Hold |
1,275
| – | – | 0.04% | 237 |
|
|
2018
Q4 | $60K | Hold |
1,275
| – | – | 0.04% | 230 |
|
|
2018
Q3 | $68K | Hold |
1,275
| – | – | 0.05% | 238 |
|
|
2018
Q2 | $64K | Hold |
1,275
| – | – | 0.05% | 241 |
|
|
2018
Q1 | $63K | Buy |
+1,275
| New | +$63K | 0.05% | 240 |
|